N
Newbury Pharmaceuticals AB
STO:NEWBRY
Newbury Pharmaceuticals AB
STO:NEWBRY
Price:
1.075
SEK
-0.92%
Market Cap:
kr32.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Newbury Pharmaceuticals AB
STO:NEWBRY
|
SE |
|
D
|
Drugs Made In America Acquisition Corp
NASDAQ:DMAA
|
US |
|
Kavango Resources PLC
LSE:KAV
|
UK |
|
Harford Bank
OTC:HFBK
|
US |
|
RC Fornax PLC
LSE:RCFX
|
UK |
|
O
|
O.B.System Inc
TSE:5576
|
JP |
|
Unicharm Corp
OTC:UNCHF
|
JP |
|
A
|
Ategrity Specialty Insurance Company Holdings
NYSE:ASIC
|
US |
|
L
|
Live Ventures Inc
NASDAQ:LIVE
|
US |
|
Dah San Electric Wire & Cable Corp
TWSE:1615
|
TW |
|
O
|
Oxiquim S A
SGO:OXIQUIM
|
CL |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NEWBRY's stock price target?
Not Available
NEWBRY doesn't have any price targets made by Wall Street professionals.
What is Newbury Pharmaceuticals AB's Revenue forecast?
Projected CAGR
351%
351%
For the last 3 years the compound annual growth rate for Newbury Pharmaceuticals AB's revenue is 79%. The projected CAGR for the next 1 year is 351%.
